CANADA, February 4, 2020 (HEMPINDUSTRY) Editor’s note: This is part of an occasional series on retailing trends in the hemp industry.
Canada’s federal health regulator is reviewing the potential market for cannabis health products that would not require physician oversight, a review that...
U.S, November 29, 2019 (CANNABISNOW) Fear-driven misinformation is permeating the national conversation about the vaping-related deaths. Here’s what you need to know.
A wave of vaping-related pulmonary illness is shaking up America. The first reported illnesses first broke out over the summer and have now killed dozens and sickened thousands...
UNITED KINGDOM, October 9, 2019, (HEALTH EUROPA) - Zelda Therapeutics Limited has announced a proposed merger of equals with Ilera Therapeutics LLC (Ilera Therapeutics).
Ilera Therapeutics is a privately held medical cannabis and cannabinoid science company based in the United States and, subject to approval from Zelda shareholders and all conditions of sale being met,...
U.S, January 20, 2020 (GREENENTREPRENEUR) CBD and THC are the most visible cannabinoids in the wellness and skincare industries today, but with more than 100 known cannabinoids, others are muscling in.
Fueled by growing consumer interest, technological innovation and an ever-expanding body of scientific...
U.S, November 27, 2019 (HEMPGAZETTE) A recent study out of Washington State University indicates inhaled cannabis may reduce the intensity of headaches and migraines.
Led by Carrie Cuttler, a WSU assistant professor of psychology, a research term analyzed information submitted by more than 1,300 patients who used the Strainprint app...
CANADA, October 2 2019 (ANALYTICALCANNABIS) Researchers at Western University, Canada, have uncovered the exact molecular mechanisms that cause CBD to block some of the negative psychiatric side effects associated with high levels of THC in cannabis.
Their study, the results of which were recently published in the Journal of Neuroscience, identified extracellular-signal regulated...